Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: Patch clamp recordings in cultured neurones and area CA1 in hippocampal slices

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1209-1221

  Rammes, Gerhard ^a   Swandulla, Dieter ^a   Collingridge, Graham L ^b   Hartmann, Sabine ^c   Parsons, Chris G ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Dept Anat Sch Med Sci U   (United Kingdom)

^c MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Allosteric interactions; AMPA receptor mediated e.p.s.cs; AMPA induced currents; Cyclothiazide; GYKI 52466; GYKI 53405; GYKI 53655; Hippocampal slice; Kinetics; Superior colliculus culture

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; BENZODIAZEPINE DERIVATIVE; CYCLOTHIAZIDE; GYKI 53406; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; DESENSITIZATION; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029928851     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16718.x     Document Type: Article

References (83)

1. ARAI, A., KESSLER, M., AMBRO-SINGERSON, J., XIAO, P., ROGERS, G. & LYNCH, G. (1994). A centrally active drug that modulates AMPA receptor gated currents. Soc. Neurosci. Abs., 20, 1511.
2. 3H]-1-glutamate release from rat hippocampal synaptosomes. Br. J. Pharmacol., 113, 339-341.
3. BERTOLINO, M., BARALDI, M., PARENTI, C., BRAGHIROLI, D., DIBELLA, M., VICINI, S. & COSTA, E. (1993). Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Recept. Channel, 1, 267-278.
4. BISAGA, A., KRZASCIK, P., JANKOWSKA, E., PALEJKO, W., KOSTOWSKI, W. & DANYSZ, W. (1993). Effect of glutamate receptor antagonists on N-methyl-D-aspartate acid and (s)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. Eur. J. Pharmacol., 242, 213-220.
5. BOULTON, C.L., IRVING, A.J., SOUTHAM, E., POTIER, B., GARTHWAITE, J. & COLLINGRIDGE, G.L. (1994). The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci., 6, 1528-1535.
6. CHAPMAN, A.G., ALZUBAIDY, Z. & MELDRUM, B.S. (1993). Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmacol., 231, 301-303.
7. CHAPMAN, A.G., SMITH, S.E. & MELDRUM, B.S. (1991). The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI-52466, in mice. Epilepsy Res., 9, 92-96.
8. CHIZH, B.A., CUMBERBATCH, M.J. & HEADLEY, P.M. (1994). A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Br. J. Pharmacol., 112, 843-846.
9. CLEMENTS, J.D., LESTER, R.A.J., TONG, G., JAHR, C.E. & WESTBROOK, G.L. (1992). The time course of glutamate in the synaptic cleft. Science, 258, 1498-1501.
10. COOGAN, M., LARSON, J., ROGERS, G. & LYNCH, G. (1994). Enhancement of synaptic transmission in hippocampus of aged rats by novel modulators of AMPA receptors. Soc. Neurosci. Abs., 20, 1512.
11. CUMBERBATCH, M.J., CHIZH, B.A. & HEADLEY, P.M. (1994). AMPA receptors have an equal role in spinal nociceptive and nonnociceptive transmission. Neuroreport, 5, 877-880.
12. DANYSZ, W., PARSONS, C.G., BRESINK, I. & QUACK, G. (1995a). Glutamate in CNS disorders - a revived target for drug development? Drug News & Perspectives, 8, 261-277.
13. DANYSZ, W., ZAJACZKOWSKI, W. & PARSONS, C.G. (1995b). Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol., 6, 455-474.
14. 3]norepinephrine release from rat hippocampal slices. J. Neurochem., 63, 231-237.
15. DESAI, M.A., BURNETT, J.P., ORNSTEIN, P.L. & SCHOEPP, D.D. (1995). Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. J. Pharmacol. Exp. Ther., 272, 38-43.
16. DONEVAN, S.D. & ROGAWSKI, M.A. (1993). GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron, 10, 51-59.
17. DONEVAN, S.D., YAMAGUCHI, S. & ROGAWSKI, M.A. (1994). Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. J. Pharmacol. Exp. Ther., 271, 25-29.
18. ENGBERG, I., TARNAWA, I., DURAND, J. & OUARDOUZ, M. (1993). An analysis of synaptic transmission to motoneurones in the cat spinal cord using a new selective receptor blocker. Acta Physiol. Scand., 148, 97-100.
19. GLOBUS, M.Y.T., BUSTO, R., MARTINEZ, E., VALDES, I., DIETRICH, W.D. & GINSBERG, M.D. (1991). Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J. Neurochem., 57, 470-478.
20. GRANGER, R., STAUBLI, U., DAVIS, M., PEREZ, Y., NILSSON, L., ROGERS, G.A. & LYNCH, G. (1993). A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task. Synapse, 15, 326-329.
21. GREENAMYRE, J.T., MARAGOS, E.F., ALBIN, R.L., PENNEY, J.B. & YOUNG, A.B. (1988). Glutamate transmission and toxicity in Alzheimer's disease. Prog. Neuro-Psych. Biol. Psych., 12, 421-430.
22. 3H]AMPA binding to rat brain membranes - evidence that AMPA receptor desensitization increases agonist affinity. Brain Res., 628, 345-348.
23. 3H]AMPA binding to AMPA receptor subunits stabley expressed in HEK 293 cells. Neurosci. Abs., 20, 484.
24. HESTRIN, S. (1992). Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortex. Neuron, 9, 991-999.
25. 2+ in cultured neurons from rat brain. J. Neurochem., 64, 2049-2056.
26. ISAACSON, J.S. & NICOLL, R.A. (1991). Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. U.S.A., 88, 10936-10940.
27. ITO, I., TANABE, S., KOHIDA, A. & SUGIYAMA, H. (1990). Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol., 424, 533-543.
28. JONAS, P. & SAKMANN, B. (1992). Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J. Physiol., 455, 143-171.
29. KISKIN, N.I., KRISHTAL, O.A. & TSYNDRENKO, A.Y. (1986). Excitatory amino acid receptors in hippocampal neurons: kainate fails to desensitize them. Neurosci. Lett., 63, 225-230.
30. LEE, C.R. & BENFIELD, P. (1994). Aniracetam - an overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. Drugs & Aging, 4, 257-273.
31. LIVSEY, C.T., COSTA, E. & VICINI, S. (1993). Glutamate-activated currents in outside-out patches from spiny versus aspiny hilar neurons of rat hippocampal slices. J. Neurosci., 13, 5324-5333.
32. LÖSCHER, W. & HÖNACK, D. (1994). Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br. J. Pharmacol., 113, 1349-1357.
33. MAY, P.C. & ROBISON, P.M. (1993a). GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. Neurosci. Lett., 152, 169-172.
34. MAY, P.C. & ROBISON, P.M. (1993b). Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures. J. Neurochem., 60, 1171-1174.
35. MAYERSOHN, M., RONCARI, G. & WENDT, G. (1993). Disposition pharmacokinetics and metabolism of aniracetam in animals. Drug Investig., 5, 73-95.
36. MISGELD, U., MÜLLER, W. & POLDER, H.R. (1989). Potentiation and suppression by eserine of muscarinic synaptic transmission in the guinea-pig hippocampal slice. J. Physiol., 409, 191-206.
37. MONCADA, C., ARVIN, B., LEPEILLET, E. & MELDRUM, B.S. (1991). Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus. Neurosci. Lett., 133, 287-290.
38. MOUDY, A.M., YAMADA, K.A. & ROTHMAN, S.M. (1994). Rapid desensitization determines the pharmacology of glutamate neurotoxicity. Neuropharmacol., 33, 953-962.
39. OTIS, T.S., RAMAN, I.M. & TRUSSEL, L.O. (1994). Voltage dependent gating of AMPA receptors on chick auditory neurons. Neurosci. Abs., 20, 485.
40. OUARDOUZ, M. & DURAND, J. (1991). GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones. Neurosci. Lett., 125, 5-8.
41. OUARDOUZ, M. & DURAND, J. (1994). Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo. Eur. J. Neurosci., 6, 1662-1668.
42. PALMER, A.J. & LODGE, D. (1993). Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI-53655. Eur. J. Pharmacol. Mol. Pharmacol., 244, 193-194.
43. PALMER, A.M. & GERSHON, S. (1990). Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J., 4, 2745-2752.
44. PARSONS, C.G., GRUNER, R. & ROZENTAL, J. (1994). Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7, 8-methylendioxyl-5H-2,3-benzo-diazepine (GYKI 52466). Neuropharmacol., 33, 589-604.
45. PARTIN, K.M., PATNEAU, D.K. & MAYER, M.L (1994a). Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol., 46, 129-138.
46. PARTIN, K.M., PATNEAU, D.K. & MAYER, M.L. (1994b). Splice variants of AMPA receptors are differentially modulated by cyclothiazide. Neurosci. Abs., 20, 484.
47. PARTIN, K.M., PATNEAU, D.K., WINTERS, C.A., MAYER, M.L. & BUONANNO, A. (1993). Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concavalin-A. Neuron, 11, 1069-1082.
48. PATNEAU, D.K. & MAYER, M.L. (1990). Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci., 10, 2385-2399.
49. PATNEAU, D.K. & MAYER, M.L. (1991). Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron, 6, 785-795.
50. PATNEAU, D.K., MAYER, M.L., JANE, D.E. & WATKINS, J.C. (1992). Activation and desensitization of AMPA/Kainate receptors by novel derivatives of willardine. J. Neurosci., 12, 595-606.
51. PATNEAU, D.K., VYKLICKY, L. & MAYER, M.L. (1993). Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J. Neurosci., 13, 3496-3509.
52. PELLETIER, M.R. & HABLITZ, J.J. (1994). Altered desensitization produces enhancement of EPSPs in neocortical neurons. J. Neurophysiol., 72, 1032-1036.
53. PIZZI, M., FALLACARA, C., ARRIGHI, V., MEMO, M. & SPANO, P. (1993). Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J. Neurochem., 61, 683-689.
54. RAMAN, I.M., ZHANG, S. & TRUSSELL, L.O. (1994). Pathway-specific variants of AMPA receptors and their contribution to neuronal signalling. J. Neurosci., 14, 4998-5010.
55. RAMMES, G., MÜLLER, W., SWANDULLA, D.,PARSONS, C.G. & COLLINGRIDGE, G.L. (1994b). Interactions of GYKI 52466 and cyclothiazide, patch and clamp studies. Soc. Neurosci. Abst., 20, 1535.
56. RAMMES, G., PARSONS, C., MÜLLER, W. & SWANDULLA, D. (1994a). Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus. Neurosci. Lett., 175, 21-24.
57. RAMMES, G., PARSONS, C.G., SWANDULLA, D. & COLLINGRIDGE, G.L. (1995). Modulation of fast glutamatergic excitatory synaptic transmission by NBQX and Cyclothiazide in the CA1 region of hippocampal slices. Soc. Neurosci. Abst., 21, 841.
58. ROCK, D.M. & CAMPBELL, G.W. (1993). Cyclothiazide and GYKI-52466 affect AMPA-induced neuronal damage of cultured cortical neurons by actions at distinct sites. Neurosci. Abs., 19, 294.
59. ROGAWSKI, M.A. (1993). Therapeutic potential of excitatory amino acid antagonists -channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci., 14, 325-331.
60. SHARP, R.L., MAY, P.C., MAYNE, N.G., SNYDER, Y.M. & BURNETT, J.P. (1994). Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes. Eur. J. Pharmacol. Mol. Pharmacol., 266, R1-R2.
61. SHEARDOWN, M.J., NIELSEN, E.O., HANSEN, A.J., JACOBSEN, P. & HONORE, T. (1990). 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline - a neuroprotectant for cerebral ischemia. Science, 247, 571-574.
62. SMITH, S.E., DURMULLER, N. & MELDRUM, B.S. (1991). The non-N-Methyl-D-Aspartate receptor antagonists, GYKI-52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol., 201, 179-183.
63. SMITH, S.E. & MELDRUM, B.S. (1992). Cerebroprotective effect of a non-N-Methyl-D-Aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke, 23, 861-864.
64. STAUBLI, U., AMBROS-INGERSON, J. & LYNCH, G. (1992). Receptor changes and LTP - an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors. Hippocampus, 2, 49-58.
65. STAUBLI, U., PEREZ, Y., XU, F.B., ROGERS, G., INGVAR, M., STONEELANDER, S. & LYNCH, G. (1994a). Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc. Natl. Acad. Sci. U.S.A., 91, 11158-11162.
66. STAUBLI, U., ROGERS, G. & LYNCH, G. (1994b). Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. U.S.A., 91, 777-781.
67. SWANDULLA, D. & MISGELD, U. (1990). Development and properties of synaptic mechanisms in a network of rat hypothalamic neurons grown in culture. J. Neurophysiol., 64, 715-726.
68. 3H]GYKI 53405 to Xenopus brain membranes. Neuroreport, 5, 93-94.
69. TANG, C.M., SHI, Q.Y., KATCHMAN, A. & LYNCH, G. (1991). Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science, 254, 288-290.
70. TARNAWA, I., BERZSENYI, P., ANDRASI, F., BOTKA, P., HAMORI, T., LING, I. & KOROSI, J. (1993). Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action. Bioorg. Med. Chem. Lett., 3, 99-104.
71. TARNAWA, I., MOLNAR, P., GAAL, L. & ANDRASI, F. (1992). Inhibition of hippocampal field potentials by GYKI-52466 in vitro and in vivo. Acta Physiol. Hung., 79, 163-169.
72. TRUSSELL, L.D. & FISCHBACH, G.D. (1989). Glutamate receptor desensitization and its role in synaptic transmission. Neuron, 3, 209-218.
73. TRUSSELL, L.O., ZHANG, S. & RAMAN, I.M. (1993). Desensitization of AMPA receptors upon multiquantal neurotransmitter release. Neuron, 10, 1185-1196.
74. VERDOORN, T.A., BURNASHEV, N., MONYER, H., SEEBURG, P.H. & SAKMANN, B. (1991). Structural determinants of ion flow-through recombinant glutamate receptor channels. Science, 252, 1715-1718.
75. VYKLICKY, L., PATNEAU, D.K. & MAYER, M.L. (1991). Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/Kainate receptors. Neuron, 7, 971-984.
76. WILDING, T.J. & HUETTNER, J.E. (1995). Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate- preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol., 47, 582-587.
77. WONG, L.A. & MAYER, M.L. (1993). Differential modulation by cyclothiazide and concavalin-A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate- preferring glutamate receptors. Mol. Pharmacol., 44, 504-510.
78. YAMADA, K.A. & TANG, C.M. (1993). Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci., 13, 3904-3915.
79. YAMADA, K.A. & TURETSKY, D. (1994). Cyclothiazide and GYKI 52466 do not competitively interact on recombinant GluR6 receptors. Neurosci. Abs., 20, 235.
80. YAMAGUCHI, S., DONEVAN, S.D. & ROGAWSKI, M.A. (1993). Anticonvulsant activity of AMPA/kainate antagonists - comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res., 15, 179-184.
81. ZHANG, S. & TRUSSELL, L.O. (1994). Voltage-dependence of the EPSC and desensitisation of AMPA receptors by transmitter. Neurosci. Abs., 20, 1715.
82. ZIVKOVIC, I., THOMPSON, D.M., BERTOLINO, M., UZUNOV, D., DIBELLA, M., COSTA, E. & GUIDOTTI, A. (1995). 7-Chloro -3-methyl-3-4-dihydro-2H-1,2,4 benzothiadizine S, S-dioxide (IDRA 21): a benzothiadizine derivative that enhances cognition by attenuating d,1-α-amino-2,3-dihydro-5-methyl-3-oxo-4-osoxazolepropionic acid (AMPA) receptor desensitization. J. Pharmacol. Exp. Ther., 272, 300-309.
83. ZORUMSKI, C.F., YAMADA, K.A., PRICE, M.T. & OLNEY, J.W. (1993). A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron, 10, 61-67.